Home LiteratureArticle Details
PMID: 6176486 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Determination of type 1 poliovirus subtype classes with neutralizing monoclonal antibodies.

Developments in biological standardization ·Vol. 50 ·1981-00-00 ·Pages 229-34

Crainic R, Couillin P, Cabau N, Boue A, Horodniceanu F

Abstract

Hybridomas secreting neutralizing monoclonal antibodies (MA) against type 1 poliovirus were developed by fusion of mouse myeloma cells with splenocytes of immunized mice. Strain-specific MA selected for their capacity to neutralize wild (Mahoney) or attenuated (Sabin, LSc 2ab) poliovirus strains were used for identification of field isolates. A simple and reliable neutralization-index-assay was developed and used to test for intratypic serodifferentiation of poliovirus with the selected MA. Three subtype classes of type 1 poliovirus have so far been identified by testing 4 reference strains and 96 field isolates: Mahoney-like, LSc-like, and strains not recognized by either anti-Mahoney or anti-LSc MA. Neutralizing MA proved an excellent tool for unequivocal antigenic characterization of different poliovirus strains.

MeSH Terms
Animals Antibodies, Monoclonal Cell Line Epitopes Hybridomas/immunology Mice Plasmacytoma Poliovirus/classification,immunology Serotyping Spleen/immunology
Chemicals
Antibodies, Monoclonal Epitopes
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Crainic R
Couillin P
Cabau N
Boue A
Horodniceanu F
Article Info
Journal
Developments in biological standardization
Abbr.
Dev Biol Stand
ISSN
0301-5149
Published
1981-00-00
Pages
229-34
Language
English
Region
Switzerland
NLM ID
0427140
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com